Skip to main content
. 2019 Jan 18;9:227. doi: 10.1038/s41598-018-36698-1

Figure 1.

Figure 1

Normalized output fraction of osteogenically primed SVF and A375 controlled-ratio sorts using FACS, manufacturer’s protocol MACS, and optimized protocol MACS. Defined mixtures of osteogenically primed SVF and A375 cells were labeled with anti-ALPL-APC antibodies (and anti-APC microbeads for MACS) prior to cell sorting. After separation, ALPL+/retained and ALPL−/flow-through fractions were counted and normalized output fractions computed. For ALPL+:ALPL− cell ratios >1:3, manufacturer’s protocol MACS sorts were not able to accurately separate ALPL+ and ALPL− cells. Error bars indicate standard deviation.